FRESENIUS MEDICAL CARE-ADR (FMS) Fundamental Analysis & Valuation
NYSE:FMS • US3580291066
Current stock price
23.63 USD
+0.02 (+0.08%)
At close:
23.63 USD
0 (0%)
After Hours:
This FMS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. FMS Profitability Analysis
1.1 Basic Checks
- FMS had positive earnings in the past year.
- In the past year FMS had a positive cash flow from operations.
- In the past 5 years FMS has always been profitable.
- FMS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- FMS has a better Return On Assets (3.16%) than 65.00% of its industry peers.
- FMS has a better Return On Equity (7.35%) than 63.00% of its industry peers.
- FMS has a Return On Invested Capital of 5.30%. This is comparable to the rest of the industry: FMS outperforms 59.00% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for FMS is below the industry average of 8.74%.
- The last Return On Invested Capital (5.30%) for FMS is above the 3 year average (4.02%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| ROIC | 5.3% |
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
1.3 Margins
- FMS has a Profit Margin of 4.98%. This is in the better half of the industry: FMS outperforms 78.00% of its industry peers.
- FMS's Profit Margin has declined in the last couple of years.
- With a decent Operating Margin value of 9.00%, FMS is doing good in the industry, outperforming 78.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of FMS has declined.
- FMS has a Gross Margin of 25.62%. This is comparable to the rest of the industry: FMS outperforms 54.00% of its industry peers.
- FMS's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9% | ||
| PM (TTM) | 4.98% | ||
| GM | 25.62% |
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
2. FMS Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FMS is creating some value.
- FMS has less shares outstanding than it did 1 year ago.
- FMS has less shares outstanding than it did 5 years ago.
- FMS has a worse debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 1.82 indicates that FMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
- FMS's Altman-Z score of 1.82 is in line compared to the rest of the industry. FMS outperforms 47.00% of its industry peers.
- The Debt to FCF ratio of FMS is 6.19, which is on the high side as it means it would take FMS, 6.19 years of fcf income to pay off all of its debts.
- FMS's Debt to FCF ratio of 6.19 is in line compared to the rest of the industry. FMS outperforms 50.00% of its industry peers.
- A Debt/Equity ratio of 0.65 indicates that FMS is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.65, FMS perfoms like the industry average, outperforming 54.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.19 | ||
| Altman-Z | 1.82 |
ROIC/WACC1.02
WACC5.19%
2.3 Liquidity
- FMS has a Current Ratio of 1.26. This is a normal value and indicates that FMS is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of FMS (1.26) is comparable to the rest of the industry.
- A Quick Ratio of 0.92 indicates that FMS may have some problems paying its short term obligations.
- FMS's Quick ratio of 0.92 is on the low side compared to the rest of the industry. FMS is outperformed by 73.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.92 |
3. FMS Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 32.00% over the past year.
- The Earnings Per Share has been decreasing by -1.51% on average over the past years.
- FMS shows a small growth in Revenue. In the last year, the Revenue has grown by 1.51%.
- The Revenue has been growing slightly by 1.91% on average over the past years.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
3.2 Future
- FMS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.03% yearly.
- FMS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.69% yearly.
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y9.03%
Revenue Next Year-0.21%
Revenue Next 2Y1.76%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. FMS Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 9.19 indicates a reasonable valuation of FMS.
- Based on the Price/Earnings ratio, FMS is valued cheaply inside the industry as 94.00% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 26.78. FMS is valued rather cheaply when compared to this.
- The Price/Forward Earnings ratio is 9.58, which indicates a very decent valuation of FMS.
- Based on the Price/Forward Earnings ratio, FMS is valued cheaply inside the industry as 90.00% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.54, FMS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.19 | ||
| Fwd PE | 9.58 |
4.2 Price Multiples
- 91.00% of the companies in the same industry are more expensive than FMS, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 92.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.46 | ||
| EV/EBITDA | 5.99 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.59%
EPS Next 3Y5.97%
5. FMS Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 3.72%, FMS has a reasonable but not impressive dividend return.
- FMS's Dividend Yield is rather good when compared to the industry average which is at 0.47. FMS pays more dividend than 98.00% of the companies in the same industry.
- FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.72% |
5.2 History
- The dividend of FMS has a limited annual growth rate of 4.43%.
- FMS has paid a dividend for at least 10 years, which is a reliable track record.
- The dividend of FMS decreased in the last 3 years.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years2
5.3 Sustainability
- FMS pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
- The dividend of FMS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.19%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
FMS Fundamentals: All Metrics, Ratios and Statistics
23.63
+0.02 (+0.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24 2026-02-24/dmh
Earnings (Next)05-05 2026-05-05
Inst Owners44.85%
Inst Owner Change0.18%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.20B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target26.46 (11.98%)
Short Float %0.49%
Short Ratio2.84
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.72% |
Yearly Dividend0.88
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-2.74%
PT rev (3m)-4.64%
EPS NQ rev (1m)4.35%
EPS NQ rev (3m)33.21%
EPS NY rev (1m)7.85%
EPS NY rev (3m)2.05%
Revenue NQ rev (1m)-0.71%
Revenue NQ rev (3m)-5.93%
Revenue NY rev (1m)-0.95%
Revenue NY rev (3m)-3.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.19 | ||
| Fwd PE | 9.58 | ||
| P/S | 0.57 | ||
| P/FCF | 6.46 | ||
| P/OCF | 4.2 | ||
| P/B | 0.85 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.99 |
EPS(TTM)2.57
EY10.88%
EPS(NY)2.47
Fwd EY10.44%
FCF(TTM)3.66
FCFY15.47%
OCF(TTM)5.62
OCFY23.79%
SpS41.15
BVpS27.91
TBVpS-3.18
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| ROCE | 7.13% | ||
| ROIC | 5.3% | ||
| ROICexc | 5.78% | ||
| ROICexgc | 16.63% | ||
| OM | 9% | ||
| PM (TTM) | 4.98% | ||
| GM | 25.62% | ||
| FCFM | 8.88% |
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.19 | ||
| Debt/EBITDA | 2.64 | ||
| Cap/Depr | 62.47% | ||
| Cap/Sales | 4.78% | ||
| Interest Coverage | 4.9 | ||
| Cash Conversion | 82.09% | ||
| Profit Quality | 178.22% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.82 |
F-Score8
WACC5.19%
ROIC/WACC1.02
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year-0.21%
Revenue Next 2Y1.76%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year70.62%
EBIT Next 3Y23.59%
EBIT Next 5Y15.26%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%
FRESENIUS MEDICAL CARE-ADR / FMS Fundamental Analysis FAQ
What is the fundamental rating for FMS stock?
ChartMill assigns a fundamental rating of 5 / 10 to FMS.
Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?
ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.
Can you provide the profitability details for FRESENIUS MEDICAL CARE-ADR?
FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for FMS stock?
The Price/Earnings (PE) ratio for FRESENIUS MEDICAL CARE-ADR (FMS) is 9.19 and the Price/Book (PB) ratio is 0.85.
Can you provide the financial health for FMS stock?
The financial health rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 3 / 10.